Avantor, Inc. (NYSE:AVTR) Receives $25.50 Consensus Target Price from Analysts

Avantor, Inc. (NYSE:AVTR) has earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $25.50.

Several analysts have commented on the stock. Barclays lowered their price objective on shares of Avantor from $26.00 to $23.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Wells Fargo & Company lowered their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Cowen reissued a “buy” rating on shares of Avantor in a report on Tuesday, March 18th. UBS Group restated a “neutral” rating and issued a $25.00 target price (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Finally, Royal Bank of Canada dropped their price target on Avantor from $33.00 to $31.00 and set an “outperform” rating on the stock in a research report on Monday, February 10th.

Avantor Stock Performance

Shares of AVTR opened at $15.25 on Friday. The stock has a 50 day moving average of $17.64 and a 200 day moving average of $20.87. The company has a market capitalization of $10.39 billion, a price-to-earnings ratio of 14.66, a PEG ratio of 1.55 and a beta of 1.24. Avantor has a 12 month low of $14.67 and a 12 month high of $28.00. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter last year, the firm posted $0.22 earnings per share. As a group, sell-side analysts forecast that Avantor will post 1.06 earnings per share for the current year.

Insider Buying and Selling

In other news, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. The trade was a 10.78 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP James Bramwell sold 3,758 shares of the company’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at approximately $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Avantor

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB boosted its position in shares of Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after acquiring an additional 625 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC lifted its position in Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after purchasing an additional 1,067 shares during the last quarter. UMB Bank n.a. lifted its position in Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after purchasing an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC purchased a new position in Avantor in the 4th quarter worth approximately $65,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.